Arkolith/Insider Trading/AEON/Form 4

Carter Eric G

DirectorAEON Biopharma, Inc. (AEON) · full profile →Form 4 · filed Mar 21, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 19, 2024Grant(A)16K—$016K
Mar 19, 2024Grant(A)8K—$08K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-037434) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML